Physiomics Plc (LON:PYC – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 0.41 ($0.01) and last traded at GBX 0.41 ($0.01), with a volume of 1370689 shares trading hands. The stock had previously closed at GBX 0.42 ($0.01).
Physiomics Stock Performance
The stock has a market cap of £841,167.83, a price-to-earnings ratio of -0.92 and a beta of 1.69. The business’s 50 day moving average is GBX 0.76 and its 200-day moving average is GBX 0.71.
Physiomics (LON:PYC – Get Free Report) last announced its earnings results on Thursday, March 6th. The company reported GBX (0.12) ($0.00) earnings per share (EPS) for the quarter. Physiomics had a negative net margin of 106.80% and a negative return on equity of 127.68%. Sell-side analysts anticipate that Physiomics Plc will post -0.13 EPS for the current fiscal year.
About Physiomics
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.
Recommended Stories
- Five stocks we like better than Physiomics
- How to Most Effectively Use the MarketBeat Earnings Screener
- How to Protect Your Portfolio When Inflation Is Rising
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What is the Euro STOXX 50 Index?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
